Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)
- PMID: 21091099
- DOI: 10.3111/13696998.2010.536350
Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)
Abstract
Objective: As a component of healthcare reform, payers, hospital administrators, and physicians are looking for ways to reduce hospital expenditures and improve efficiency. The economic benefit of a reduced hospital stay must be weighed against the cost of the treatment or process necessary to achieve the reduced length of stay (LOS). The objective of this paper was to estimate the potential economic benefit of a reduction in inpatient hospital LOS for a common type of admission, community acquired pneumonia (CAP).
Research design and methods: Data for this study were from the CAP hospital admissions selected from the 2006 Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS). Potential savings associated with a 1 day reduction in CAP LOS were estimated using three methods: (1) average cost, (2) weighted-average incremental cost of an additional day, and (3) weighted-average predicted mean costs from regression models which were used to estimate incremental cost adjusting for hospitalization characteristics.
Main outcome measures: Cost per day of CAP hospitalization.
Results: A total of 1,471,295 CAP admissions qualified for the analysis. The cost for each day of reduction in LOS in 2009 US dollars was $2273, $2373, and $2319 for the three methods: simple average, incremental, and regression, respectively. Subgroup analysis and regression analysis indicated higher costs were identified: in patients who died in the hospital, had hospital stays in the Northeast or West, and in large hospitals. Longer CAP hospitalizations had a higher cost per additional day. Limitations include those typically associated with the use of administrative claims (e.g., lack of clinical detail, issues related to diagnosis coding).
Conclusions: Eliminating a day during the course of a CAP admission is potentially worth $2273-2373 in economic benefits (2009 dollars). As we strive for greater efficiency in healthcare delivery, changes in processes and/or improved diagnostics or treatments may potentially achieve a reduction in the length of stay. The cost of such changes or improvements must be weighed against the economic benefit of a shorter hospitalization.
Similar articles
-
Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.Curr Med Res Opin. 2009 Sep;25(9):2151-7. doi: 10.1185/03007990903102743. Curr Med Res Opin. 2009. PMID: 19601711
-
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.Curr Med Res Opin. 2010 Feb;26(2):355-63. doi: 10.1185/03007990903482418. Curr Med Res Opin. 2010. PMID: 19995325
-
Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.Scand J Infect Dis. 2013 Mar;45(3):219-26. doi: 10.3109/00365548.2012.726737. Epub 2012 Oct 31. Scand J Infect Dis. 2013. PMID: 23113827
-
Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?Clin Infect Dis. 2001 Mar 1;32(5):728-41. doi: 10.1086/319216. Epub 2001 Feb 28. Clin Infect Dis. 2001. PMID: 11229840 Review.
-
Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.Scand J Infect Dis Suppl. 1995;97:1-60. Scand J Infect Dis Suppl. 1995. PMID: 8584866 Review.
Cited by
-
Time to Recovery from COVID-19 and Its Predictors in Patients Hospitalized at Tibebe Ghion Specialized Hospital Care and Treatment Center, A Retrospective Follow-Up Study, North West Ethiopia.Glob Health Epidemiol Genom. 2023 Sep 12;2023:5586353. doi: 10.1155/2023/5586353. eCollection 2023. Glob Health Epidemiol Genom. 2023. PMID: 37731530 Free PMC article.
-
Analysis of Resident and Attending Physician End-of-Rotation Changeover Days and Association With Patient Length of Stay.JAMA Netw Open. 2023 Mar 1;6(3):e234516. doi: 10.1001/jamanetworkopen.2023.4516. JAMA Netw Open. 2023. PMID: 36951860 Free PMC article.
-
Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of COVID-19.Clinicoecon Outcomes Res. 2020 Dec 2;12:723-731. doi: 10.2147/CEOR.S280461. eCollection 2020. Clinicoecon Outcomes Res. 2020. PMID: 33293840 Free PMC article.
-
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models.Am Health Drug Benefits. 2019 Jun-Jul;12(4):168-176. Am Health Drug Benefits. 2019. PMID: 31428234 Free PMC article.
-
Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective.Am Health Drug Benefits. 2019 Feb;12(1-Supplement 1):S1-S12. Am Health Drug Benefits. 2019. PMID: 30996766 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
